or Try an Advanced Search...

    Alpha 1 Antitrypsin Stocks List

    Symbol Grade Name % Change
    KRRO C Korro Bio, Inc. -7.08
    BAX C Baxter International Inc. -1.71
    CNTA D Centessa Pharmaceuticals plc -5.60
    KMDA D Kamada Ltd. 0.39
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Antitrypsin Deficiency Biopharmaceutical Hemophilia A Medicine Alpha 1 Antitrypsin Deficiency Anesthesia Autosomal Dominant Polycystic Kidney Disease Biosurgery Products Blood Blood Plasma Blood Products Bronchiectasis Burns Cancer Cardiac Surgery Coagulation Coagulation System Compounding Cutaneous Squamous Cell Carcinoma Cystic Fibrosis

    Related ETFs - A few ETFs which own one or more of the above listed Alpha 1 Antitrypsin stocks.

    Symbol Grade Name Weight
    IHI C iShares U.S. Medical Devices ETF 2.61
    BLCV B BlackRock Large Cap Value ETF 2.21
    MDEV C First Trust Indxx Medical Devices ETF 2.12
    CZA B Guggenheim Mid-Cap Core ETF 1.62
    QDIV B Global X S&P 500 Quality Dividend ETF 1.62
    View all Alpha 1 Antitrypsin ETFs...
    Compare ETFs
    Compare BLCV to MDEV Compare IHI to BLCV Compare IHI to MDEV

        Alpha 1 Antitrypsin Stocks Recent News

        Date Stock Title
        Apr 25 BAX ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
        Apr 24 CNTA Centessa: Hemophilia B Data Readout In 2024 Is Major Turning Point
        Apr 24 CNTA Centessa Pharmaceuticals prices $100M ADS offering
        Apr 24 CNTA Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
        Apr 23 CNTA Centessa Pharmaceuticals announces $100M proposed public offering of American Depositary Shares
        Apr 23 CNTA Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
        Apr 22 CNTA Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Antitrypsin Deficiency Biopharmaceutical Hemophilia A Medicine Alpha 1 Antitrypsin Deficiency Anesthesia Autosomal Dominant Polycystic Kidney Disease Biosurgery Products Blood Blood Plasma Blood Products Bronchiectasis Burns Cancer Cardiac Surgery Coagulation Coagulation System Compounding Cutaneous Squamous Cell Carcinoma Cystic Fibrosis
        Alpha 1 Antitrypsin

        Alpha 1 Antitrypsin (AAT) is a protein produced in the liver that helps protect the lungs from damage caused by certain enzymes. It is a major component of the body's natural defense system against inflammation and infection. AAT deficiency is a rare genetic disorder that can lead to serious lung and liver damage.

        Browse All Tags